Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-769-1 | CAS number: 868-14-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Tartaric acid is skin and eye irritant.
Tartaric acid salts are not skin/eye irritant.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation / corrosion
- Remarks:
- other: medical monitoring
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study has been assessed for the use in a category approach. According to the methodology and to the extent of available details, the study has been judged as reliable with restrictions.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Evaluation of human workers occupationally-exposed to tartaric acid.
The study reports the results of un investigation carried out in a factory producing tartaric acid in order to evaluate the effects of occupational exposure to tartaric acid. A group of 74 subjects exposed to the acid and a group of 30 subjects not exposed, as a means of control, were submitted to unamnestic questionnaire. - GLP compliance:
- not specified
- Species:
- human
- Strain:
- other: not applicable
- Type of coverage:
- other: Evaluation of human workers occupationally-exposed to tartaric acid.
- Preparation of test site:
- not specified
- Vehicle:
- not specified
- Controls:
- other: subject not exposed to tartaric acid
- Amount / concentration applied:
- no data
- Duration of treatment / exposure:
- no data
- Observation period:
- no data
- Number of animals:
- Selection of the subjects:
- 74 workers
44 subjects belonging to risk group, assigned the production of tartaric acid.
30 subjects belonging to the control group (not exposed to tartaric acid)
- history evaluated for each subject: occupational, family, medical - Details on study design:
- no data
- Irritation parameter:
- other: Skin irritation
- Basis:
- other: Human observations
- Irritant / corrosive response data:
- no data
- Other effects:
- no data
- Interpretation of results:
- irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test substance is concluded to be irritating to the skin.
- Executive summary:
The investigations carried out have shown cutaneous lesions which developped with a different mode of action and a significantly greater frequency compared to the control group. The skin lesions were localized in the most part of cases in hands and were linked to the direct contact to the powder.
Reference
Responses to the questionnaires
Examined group |
skin disorder |
eye disorder |
exposed |
34* (77.3%) |
23 (52.3%) |
control group not exposed |
6 (20%) |
8 (26.7%) |
* p <0.001 data statistically significant.
Skin disorders
The skin disorders were observed in 34 subjects exposed to the substance (77.3%) and in 6 subjects not exposed to the substance (20%).
The most frequent symptoms in the exposed group are represented by:
- Acute skin irritation (30 cases)
- Skin irritation in the hands (24 cases)
- Irritation of the face and scalp (6 cases)
- Chronic cutaneous alterations (l0 cases)
- Periungual ulcers and fissures (22 cases)
Visual disorders
For what concern the visual apparatus, the results were acute irritation in 23 of the subjects exposed to the substance (52.3%) and in 8 of the subjects non-exposed to the substance (26.7%).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation
- Remarks:
- other: human monitoring
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study has been assessed for the use in a category approach. According to the methodology and to the extent of available details, the study has been judged as reliable with restrictions.
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Evaluation of human workers occupationally-exposed to tartaric acid.
The study reports the results of un investigation carried out in a factory producing tartaric acid in order to evaluate the effects of occupational exposure to tartaric acid. A group of 74 subjects exposed to the acid and a group of 30 subjects not exposed, as a means of control, were submitted to unamnestic questionnaire. - GLP compliance:
- not specified
- Species:
- human
- Strain:
- other: not applicable
- Vehicle:
- not specified
- Controls:
- yes
- Duration of treatment / exposure:
- no data
- Observation period (in vivo):
- no data
- Number of animals or in vitro replicates:
- election of the subjects:
- 74 workers
44 subjects belonging to risk group, assigned the production of tartaric acid.
30 subjects belonging to the control group (not exposed to tartaric acid)
- history evaluated for each subject: occupational, family, medical - Irritation parameter:
- other: eye irritation
- Basis:
- other: human observation
- Reversibility:
- not specified
- Other effects:
- no data
- Interpretation of results:
- irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The results obtained showed that the substance is irritating but data were not statistically significant.
- Executive summary:
The investigations carried out have shown cutaneous lesions which developped with a different mode of action and a significantly greater frequency compared to the control group.
For what concern the visual apparatus, the results were acute irritation in 23 of the subjects exposed to the substance (52.3%) and in 8 of the subjects non-exposed to the substance (26.7%).
Reference
Responses to the questionnaires
Examined group |
skin disorder |
eye disorder |
exposed |
34* (77.3%) |
23 (52.3%) |
control group not exposed |
6 (20%) |
8 (26.7%) |
* p <0.001 data statistically significant.
Skin disorders
The skin disorders were observed in 34 subjects exposed to the substance (77.3%) and in 6 subjects not exposed to the substance (20%).
The most frequent symptoms in the exposed group are represented by:
- Acute skin irritation (30 cases)
- Skin irritation in the hands (24 cases)
- Irritation of the face and scalp (6 cases)
- Chronic cutaneous alterations (l0 cases)
- Periungual ulcers and fissures (22 cases)
Visual disorders
For what concern the visual apparatus, the results were acute irritation in 23 of the subjects exposed to the substance (52.3%) and in 8 of the subjects non-exposed to the substance (26.7%).
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In order to assess the irritating potential, tartaric acid has to be considered independently by its salts. Indeed, the acid has a low pH value whereas its salts have values greater than or equal to 3.
Based on clinical investigations (human data), tartaric acid is deemed to be irritant for both skin and eye. Indeed, skin and eye irritation signs were observed in several workers who handled the substance. Also respiratory irritation was observed; however, this effect was judged by the (medical) authors to be related to the overall dustiness of the investigated work environment.
With regard to tartaric acid salts, hydrogen potassium tartrate (pH = 3) was injected in the rabbit ocular chamber and did not cause any significant adverse effect. In a clinical study, a solution of sodium hydrogen tartrate (pH = 3.5) was tested in human eye in order to assess its irritating potential. Although the test solution caused moderate stinging and a sensation of dryness, no injury was observed. The same test solution neutralized at pH 6 did not cause discomfort.
In the same way, a solution of tartaric acid neutralized at pH 3 (adding sodium phosphate) was tested on human eye. As result, severe stinging was felt by the tested subject but no injury was observed.
Overall, the pH is deemed to be the factor driving the irritating potential of these substances. In particular, it was observed that the handling of tartaric acid (which has a pH close to 2) was associated with significant skin/eye reactions. By contrast, test substances/solutions at pH equal to or higher than 3 caused only discomfort but no significant irritating effect (intended as damage or adverse reaction).
In conclusion, tartaric acid should be considered to be a sever skin/eye irritant. On the other hand, considering that the pH values of the tartaric acid salts are equal to or greater than 3, these substances should not be considered as non-irritant for both skin and eye.
Justification for selection of skin irritation / corrosion endpoint:
This endpoint study record has been selected since it contains human data which should be considered as priority in accordance with REACH and CLP regulations.
Justification for selection of eye irritation endpoint:
This endpoint study record has been selected since it contains human data which should be considered as priority in accordance with REACH and CLP regulations.
Effects on skin irritation/corrosion: irritating
Effects on eye irritation: highly irritating
Justification for classification or non-classification
According to Directive 67/548/EEC and to Regulation (EC) n. 1272/2008, the study results indicate that tartaric acid should be classified as "Xi; R38" and as "skin irritant, category 2 (H315)", respectively.
According to Directive 67/548/EEC and to Regulation (EC) n. 1272/2008, the study results indicate that tartaric acid should be classified as "Xi; R41" and as "eye damage, category 1 (H318)", respectively.
According to Directive 67/548/EEC and to Regulation (EC) n. 1272/2008, the study results indicate that the tartaric acid salts should not be classified for the skin/eye irritation because the data are judged as "conclusive but not sufficient for classification".
According to Directive 67/548/EEC and to Regulation (EC) n. 1272/2008, study results indicate that tartaric acid and its salts should not be classified for specific target organ toxicity - single exposure (H335) because data are judged as "inconclusive".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.